Skip to main content

Nutrien Ltd(NTR-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Nutrien Ltd up on Tuesday (NTR)

Automated Summaries - The Globe and Mail - Tue May 7, 4:01PM CDT

Nutrien Ltd opened trading today at $74.00 and closed at $75.82. Intraday prices ranged from a low of $73.99 to a high of $75.96.

The price advanced 2.74% from the previous day's close of $73.80.

During the day across North America, the TSX Composite closed 1.42% at 22259.47, the S&P 500 closed 1.03% at 5180.74, the Dow Jones Industrial Average closed 0.46% at 38852.27 and the Nasdaq Composite closed 1.19% at 16349.25.

Nutrien Ltd has listed on the Toronto Stock Exchange (TSX) under the ticker NTR.

Trading volume was 848,740 on 5,061 total trades. On average, Nutrien Ltd has traded 760,098 shares over the last 5-days and 1,259,138 year-to-date.

Trading across the entire TSX saw 2,888 price advancers against 2,298 declines and 125 unchanged.

During the prior 52 weeks, NTR.TO has traded as high as $92.48 (August 10,2023) and low as $64.89 (February 14,2024). Moreover, the shares have eased -12.88 percent in the last year, while they have advanced 1.57% year-to-date.

It announced a 0.54 dividend on February 21/24, with an March 27/24 ex-date and April 11/24 pay day.

Following today's trading, Nutrien Ltd has a market capitalization of $36.50 billion on a float of 494,583 shares outstanding. Its annual EPS is $2.53.

Nutrien Ltd is a TSX Agricultural Inputs company headquartered in Saskatoon, CAN.

Nutrien Ltd is holding an average recommendation of "Moderate Buy" from 21.00 analysts according to Zacks. Currently, there are 14 buy ratings, 2 sell ratings and 5 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe